EDG-2 (W45) Peptide 
Datasheet
COA
MSDS
SHIP
Product Name :
EDG-2 (W45) Peptide Applications :
Blocking Background :
The EDG (endothelial differentiation gene) family of G protein-coupled receptors consists of eight family members that bind lysophospholipid (LPL) mediators, including sphingosine-1-phosphate (SPP) and lysophosphatidic acid (LPA). EDG-1, EDG-3, EDG-5 (also designated H218 and AGR16) and EDG-8 bind SPP with high affinity. EDG-6 is a low affinity receptor for SPP. LPA preferentially binds to EDG-2, EDG-4 and EDG-7. The EDG receptors couple to multiple G proteins to signal through Ras, MAP kinase, Rho, Phospholipase C or other tyrosine kinases, which lead to cell survival, growth, migration and differentiation. EDG-1 signals through Gi proteins to activate Akt and is expressed in glioma cells. EDG-2 is expressed in brain, especially in white matter tract regions, while EDG-3 is expressed in cardiovascular tissue and in cerebellum. EDG-4 is highly expressed on leukocytes and brain, and EDG-5 has wide tissue distribution, including cardiovascular tissue and brain. Expressed in lymphoid and hematopoietic tissues and in lung, EDG-6 signals through Gi/o proteins, which activate growth related pathways. Alternative Name :
EDG2; LPA receptor 1; LPA-1; Lysophosphatidic acid receptor Edg-2; EDG2; 1902; EDG2; 602282; Q92633; Gpcr26; LPA1; LPAR1; Mrec1.3; edg-2; rec.1.3; vzg-1; Swiss-Prot :
Q92633 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide EDG-2 (W45). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS2695 EDG-2 (W45) pAb.
EDG-2 (W45) Peptide Applications :
Blocking Background :
The EDG (endothelial differentiation gene) family of G protein-coupled receptors consists of eight family members that bind lysophospholipid (LPL) mediators, including sphingosine-1-phosphate (SPP) and lysophosphatidic acid (LPA). EDG-1, EDG-3, EDG-5 (also designated H218 and AGR16) and EDG-8 bind SPP with high affinity. EDG-6 is a low affinity receptor for SPP. LPA preferentially binds to EDG-2, EDG-4 and EDG-7. The EDG receptors couple to multiple G proteins to signal through Ras, MAP kinase, Rho, Phospholipase C or other tyrosine kinases, which lead to cell survival, growth, migration and differentiation. EDG-1 signals through Gi proteins to activate Akt and is expressed in glioma cells. EDG-2 is expressed in brain, especially in white matter tract regions, while EDG-3 is expressed in cardiovascular tissue and in cerebellum. EDG-4 is highly expressed on leukocytes and brain, and EDG-5 has wide tissue distribution, including cardiovascular tissue and brain. Expressed in lymphoid and hematopoietic tissues and in lung, EDG-6 signals through Gi/o proteins, which activate growth related pathways. Alternative Name :
EDG2; LPA receptor 1; LPA-1; Lysophosphatidic acid receptor Edg-2; EDG2; 1902; EDG2; 602282; Q92633; Gpcr26; LPA1; LPAR1; Mrec1.3; edg-2; rec.1.3; vzg-1; Swiss-Prot :
Q92633 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide EDG-2 (W45). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS2695 EDG-2 (W45) pAb.
Blocking peptide available as BS2695PP